Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Shanmugasundaram, Ramkumar"'
Autor:
Thomson, David, Cruickshank, Clare, Baines, Helen, Banner, Russell, Beasley, Matthew, Betts, Guy, Bulbeck, Helen, Charlwood, Frances, Christian, Judith, Clarke, Matthew, Donnelly, Olly, Foran, Bernadette, Gillies, Callum, Griffin, Clare, Homer, Jarrod J., Langendijk, Johannes A., Lee, Lip Wai, Lester, James, Lowe, Matthew, McPartlin, Andrew, Miles, Elizabeth, Nutting, Christopher, Palaniappan, Nachi, Prestwich, Robin, Price, James M., Roberts, Clare, Roe, Justin, Shanmugasundaram, Ramkumar, Simões, Rita, Thompson, Anna, West, Catharine, Wilson, Lorna, Wolstenholme, Jane, Hall, Emma
Publikováno v:
In Clinical and Translational Radiation Oncology November 2022
Autor:
Shing Yau Tam, Victor C. W. Tam, Shanmugasundaram Ramkumar, May Ling Khaw, Helen K. W. Law, Shara W. Y. Lee
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Photobiomodulation (PBM) using low-level laser therapy (LLLT) is a treatment that is increasingly used in oncology. Studies reported enhancement of wound healing with reduction in pain, tissue swelling and inflammatory conditions such as radiation de
Externí odkaz:
https://doaj.org/article/c73b4ed6d96d46839ddbde4eebb19467
Autor:
Maura L. Gillison, Li Li, Mark Lynch, Fernando Concha-Benavente, A. Dimitrios Colevas, Makoto Tahara, Peter Brossart, Jeffery Russell, Shanmugasundaram Ramkumar, Robert Haddad, Nabil F. Saba, Everett E. Vokes, Joel Guigay, Kevin J. Harrington, George Blumenschein, Caroline Even, Jerome Fayette, Lisa Licitra, Robert L. Ferris
Purpose:Cetuximab, which modulates immune responses, may affect the efficacy of subsequent immunotherapy. Here, we assessed outcomes with nivolumab, by prior cetuximab exposure, in patients with recurrent or metastatic (R/M) squamous cell carcinoma o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14c8858f9dc86e6425bdd15ad400eea5
https://doi.org/10.1158/1078-0432.c.6527570
https://doi.org/10.1158/1078-0432.c.6527570
Autor:
Maura L. Gillison, Li Li, Mark Lynch, Fernando Concha-Benavente, A. Dimitrios Colevas, Makoto Tahara, Peter Brossart, Jeffery Russell, Shanmugasundaram Ramkumar, Robert Haddad, Nabil F. Saba, Everett E. Vokes, Joel Guigay, Kevin J. Harrington, George Blumenschein, Caroline Even, Jerome Fayette, Lisa Licitra, Robert L. Ferris
Tables S1-S5, Figures S1, S2 Supplementary Table S1. Summary of prior systemic cancer therapies in {greater than or equal to}2% of patients with prior cetuximab exposure Supplementary Table S2. Summary of prior systemic cancer therapies in {greater t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e4587f697f41a21236e9ffb4faf67b5
https://doi.org/10.1158/1078-0432.22470443.v1
https://doi.org/10.1158/1078-0432.22470443.v1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dorothy M. Gujral, Kevin J. Harrington, Win Soe, Aisha Miah, M. Emson, David Bernstein, Katie Wood, James P Morden, Amen Sibtain, Matthew Beasley, Deborah Gardiner, Nachi Palaniappan, Audrey Cook, Teresa Guerrero Urbano, Shelia Fisher, Tom Roques, M. Rizwanullah, Mehmet Sen, Paul Sanghera, Emma Hall, Christopher D Scrase, Vivian P Cosgrove, Christopher M. Nutting, Clare Griffin, Shanmugasundaram Ramkumar, Elizabeth Junor, Shreerang Bhide, Catherine M West, Bernadette Foran, Hisham Mehanna
Publikováno v:
European Journal of Cancer. 153:242-256
Background Radical (chemo)radiotherapy offers potentially curative treatment for patients with locally advanced laryngeal or hypopharyngeal cancer. We aimed to show that dose-escalated intensity-modulated radiotherapy (DE-IMRT) improved locoregional
Publikováno v:
BMJ Case Reports; Jan2024, Vol. 17 Issue 1, p1-3, 3p
Autor:
Jeffery S. Russell, Shanmugasundaram Ramkumar, Everett E. Vokes, Robert L. Ferris, Makoto Tahara, Maura L. Gillison, Lisa Licitra, Mark Lynch, Robert I. Haddad, Joël Guigay, Caroline Even, Nabil F. Saba, Kevin J. Harrington, Fernando Concha-Benavente, Jérôme Fayette, Li Li, Peter Brossart, George R. Blumenschein, A. Dimitrios Colevas
Publikováno v:
Clin Cancer Res
Purpose: Cetuximab, which modulates immune responses, may affect the efficacy of subsequent immunotherapy. Here, we assessed outcomes with nivolumab, by prior cetuximab exposure, in patients with recurrent or metastatic (R/M) squamous cell carcinoma
Autor:
May Ling Khaw, Shanmugasundaram Ramkumar, Victor C. W. Tam, Shing Yau Tam, Shara W. Y. Lee, Helen K. W. Law
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Photobiomodulation (PBM) using low-level laser therapy (LLLT) is a treatment that is increasingly used in oncology. Studies reported enhancement of wound healing with reduction in pain, tissue swelling and inflammatory conditions such as radiation de